CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 97 enrolled
Drug / intervention
Transcorneal Electrical Stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02019927
NCT02019927N/ACompleted
CompareCT.gov

Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma

Wills Eye·interventional·Posted Dec 24, 2013·Updated Jan 18, 2020

In Brief

A clinical study evaluating Transcorneal Electrical Stimulation and Sham for Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) and 2 related conditions. Completed, enrolled 97 participants across 1 site.

Detailed Summary

Transcorneal Electrical Stimulation (TES) using the "OkuStim®" device delivers electrical impulses to damaged and/or diseased photoreceptor cells. This electric stimulation of the retina may help to preserve visual acuity and/or the visual field.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-arteritic Anterior Ischemic Optic Neuropathy (NAION), Trauma, Multiple Sclerosis (MS)
CountriesUnited States
CollaboratorsUnited States Department of Defense

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 24, 2013
Enrollment StartJul 1, 2013
Primary CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 12.5 years ago

Interventions

Transcorneal Electrical Stimulationdevice

The clinical trial will investigate whether Transcorneal Electrical Stimulation delivered by the Okuvision Stimulation Set manufactured by Okuvision GmbH, Reutlingen, Germany, is a potentially effective therapy for the restoration and rehabilitation of vision loss as measured by improvements in visual acuity in the following three patient populations: patients with ocular trauma, patients with optic neuritis associated with multiple sclerosis and patients with Non-arteritic Anterior Ischemic Optic Neuropathy.

Shamdevice

Sham